Cetera Advisors LLC lessened its stake in shares of Walgreens Boots Alliance Inc (NASDAQ:WBA) by 12.1% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 19,719 shares of the pharmacy operator’s stock after selling 2,718 shares during the quarter. Cetera Advisors LLC’s holdings in Walgreens Boots Alliance were worth $1,524,000 at the end of the most recent reporting period.
Other large investors also recently made changes to their positions in the company. Franklin Resources Inc. boosted its holdings in shares of Walgreens Boots Alliance by 24.7% during the second quarter. Franklin Resources Inc. now owns 18,502,701 shares of the pharmacy operator’s stock worth $1,448,939,000 after purchasing an additional 3,662,302 shares during the last quarter. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Walgreens Boots Alliance by 471.4% during the second quarter. Arrowstreet Capital Limited Partnership now owns 3,295,583 shares of the pharmacy operator’s stock worth $258,077,000 after purchasing an additional 2,718,800 shares during the last quarter. Vanguard Group Inc. boosted its holdings in shares of Walgreens Boots Alliance by 2.8% during the second quarter. Vanguard Group Inc. now owns 69,985,653 shares of the pharmacy operator’s stock worth $5,480,577,000 after purchasing an additional 1,926,108 shares during the last quarter. Glenview Capital Management LLC acquired a new stake in shares of Walgreens Boots Alliance during the second quarter worth $136,875,000. Finally, Harding Loevner LP boosted its holdings in shares of Walgreens Boots Alliance by 85.3% during the third quarter. Harding Loevner LP now owns 2,844,207 shares of the pharmacy operator’s stock worth $115,725,000 after purchasing an additional 1,309,179 shares during the last quarter. Hedge funds and other institutional investors own 61.18% of the company’s stock.
Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $76.07 on Friday. The company has a debt-to-equity ratio of 0.48, a current ratio of 0.96 and a quick ratio of 0.47. The firm has a market capitalization of $75,340.00, a price-to-earnings ratio of 21.01, a P/E/G ratio of 1.28 and a beta of 1.22. Walgreens Boots Alliance Inc has a 52-week low of $63.82 and a 52-week high of $88.00.
Walgreens Boots Alliance (NASDAQ:WBA) last issued its earnings results on Thursday, January 4th. The pharmacy operator reported $1.28 earnings per share for the quarter, topping the consensus estimate of $1.27 by $0.01. The business had revenue of $30.74 billion for the quarter, compared to analyst estimates of $30.39 billion. Walgreens Boots Alliance had a return on equity of 19.15% and a net margin of 3.19%. The business’s quarterly revenue was up 7.9% on a year-over-year basis. During the same period last year, the company posted $1.10 EPS. analysts predict that Walgreens Boots Alliance Inc will post 5.67 earnings per share for the current fiscal year.
Walgreens Boots Alliance declared that its board has approved a stock repurchase plan on Wednesday, October 25th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the pharmacy operator to repurchase shares of its stock through open market purchases. Shares repurchase plans are usually a sign that the company’s board of directors believes its stock is undervalued.
In related news, Director John Anthony Lederer acquired 20,000 shares of the business’s stock in a transaction on Thursday, October 26th. The shares were bought at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the completion of the transaction, the director now directly owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the completion of the transaction, the director now directly owns 16,415 shares in the company, valued at $1,105,878.55. The disclosure for this sale can be found here. Company insiders own 14.80% of the company’s stock.
Several research firms have recently issued reports on WBA. BidaskClub upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Wednesday. Needham & Company LLC restated a “buy” rating and set a $88.00 price objective (up previously from $86.00) on shares of Walgreens Boots Alliance in a report on Wednesday. Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $82.00 price objective on the stock in a report on Saturday. Pivotal Research set a $73.00 price objective on Walgreens Boots Alliance and gave the stock a “hold” rating in a report on Friday, January 5th. Finally, Loop Capital set a $90.00 price objective on Walgreens Boots Alliance and gave the stock a “buy” rating in a report on Wednesday, January 3rd. Nine analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company. Walgreens Boots Alliance presently has an average rating of “Buy” and a consensus price target of $86.20.
About Walgreens Boots Alliance
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.